Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Prostatic Neoplasms × Cytarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 232 Leukemia 163 Precursor Cell Lymphoblastic Leukemia-Lymphoma 106 Lymphoma 87 Congenital Abnormalities 55 Myelodysplastic Syndromes 52 Leukemia, Myelomonocytic, Acute 50 Leukemia, Monocytic, Acute 50 Leukemia, Erythroblastic, Acute 48 Leukemia, Megakaryoblastic, Acute 46 Lymphoma, Non-Hodgkin 44 Burkitt Lymphoma 36 Lymphoma, Mantle-Cell 34 Lymphoma, Large B-Cell, Diffuse 34 Lymphoma, Follicular 28 Leukemia, Myelomonocytic, Chronic 25 Hodgkin Disease 24 Lymphoma, Large-Cell, Immunoblastic 22 Anemia, Refractory, with Excess of Blasts 22 Leukemia, Lymphocytic, Chronic, B-Cell 21 Blast Crisis 20 Recurrence 17 Myeloproliferative Disorders 17 Leukemia, Eosinophilic, Acute 15 Lymphoma, B-Cell, Marginal Zone 14 Leukemia, Promyelocytic, Acute 14 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 Leukemia, Myeloid, Chronic-Phase 13 Leukemia, Biphenotypic, Acute 13 Leukemia, Basophilic, Acute 13

Interventions

Docetaxel 144 Prednisone 108 Leuprolide 81 enzalutamide 69 Radiotherapy 69 bicalutamide 68 Goserelin 66 Abiraterone Acetate 65 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 47 Zoledronic Acid 36 Magnetic Resonance Spectroscopy 34 Estramustine 28 abiraterone 27 gallium 68 PSMA-11 26 apalutamide 26 Flutamide 26 radium Ra 223 dichloride 24 Radiosurgery 22 Gonadotropin-Releasing Hormone 21 Dutasteride 20 Androgen Antagonists 20 sipuleucel-T 19 cabazitaxel 19 Surveys and Questionnaires 18 Radiation 18 Exercise 17 Brachytherapy 17 luprolide acetate gel depot 16 Triptorelin Pamoate 16 Prednisolone 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00480090 2019-02-15

SLAP

University Health Network, Toronto

Phase 2 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡